Efficacy of a dilemma-focused intervention for unipolar depression: study protocol for a multicenter randomized controlled trial by Feixas, Guillem et al.
TRIALS
Feixas et al. Trials 2013, 14:144
http://www.trialsjournal.com/content/14/1/144STUDY PROTOCOL Open AccessEfficacy of a dilemma-focused intervention for
unipolar depression: study protocol for a
multicenter randomized controlled trial
Guillem Feixas1,2*, Arturo Bados1, Eugeni García-Grau1, Adrián Montesano1, Gloria Dada1, Victoria Compañ1,
Mari Aguilera1, Marta Salla1, Joan Miquel Soldevilla1, Adriana Trujillo1, Clara Paz1, Lluís Botella3, Sergi Corbella3,
Luis Ángel Saúl-Gutiérrez4, José Cañete5, Miquel Gasol6, Montserrat Ibarra7, Leticia Medeiros-Ferreira8,
José Soriano9, Eugénia Ribeiro10, Franz Caspar11 and David Winter12Abstract
Background: Depression is one of the more severe and serious health problems because of its morbidity, disabling
effects and for its societal and economic burden. Despite the variety of existing pharmacological and psychological
treatments, most of the cases evolve with only partial remission, relapse and recurrence.
Cognitive models have contributed significantly to the understanding of unipolar depression and its psychological
treatment. However, success is only partial and many authors affirm the need to improve those models and also the
treatment programs derived from them. One of the issues that requires further elaboration is the difficulty these
patients experience in responding to treatment and in maintaining therapeutic gains across time without relapse or
recurrence. Our research group has been working on the notion of cognitive conflict viewed as personal dilemmas
according to personal construct theory. We use a novel method for identifying those conflicts using the repertory grid
technique (RGT). Preliminary results with depressive patients show that about 90% of them have one or more of those
conflicts. This fact might explain the blockage and the difficult progress of these patients, especially the more severe
and/or chronic. These results justify the need for specific interventions focused on the resolution of these internal
conflicts. This study aims to empirically test the hypothesis that an intervention focused on the dilemma(s) specifically
detected for each patient will enhance the efficacy of cognitive behavioral therapy (CBT) for depression.
Design: A therapy manual for a dilemma-focused intervention will be tested using a randomized clinical trial by
comparing the outcome of two treatment conditions: combined group CBT (eight, 2-hour weekly sessions) plus
individual dilemma-focused therapy (eight, 1-hour weekly sessions) and CBT alone (eight, 2-hour group weekly sessions
plus eight, 1-hour individual weekly sessions).
Method: Participants are patients aged over 18 years meeting diagnostic criteria for major depressive disorder or
dysthymic disorder, with a score of 19 or above on the Beck depression inventory, second edition (BDI-II) and
presenting at least one cognitive conflict (implicative dilemma or dilemmatic construct) as assessed using the RGT. The
BDI-II is the primary outcome measure, collected at baseline, at the end of therapy, and at 3- and 12-month follow-up;
other secondary measures are also used.
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Discussion: We expect that adding a dilemma-focused intervention to CBT will increase the efficacy of one of the
more prestigious therapies for depression, thus resulting in a significant contribution to the psychological treatment
of depression.
Trial registration: ISRCTN92443999; ClinicalTrials.gov Identifier: NCT01542957.
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Depression is an often chronic and recurring health
problem, with relapse rates ranging between 50 to 80%
and approximately 120 million people currently affected
worldwide. An increase in this figure is expected [1],
and its lifetime prevalence can be up to 15% [2] - this
constituting the leading cause of years lived with dis-
ability. In 2001, depression was the fourth main cause of
morbidity and estimates indicate that, by 2020, it could
rise to second place, after cardiovascular diseases [3,4].
Nowadays, depression is considered to present a pre-
dominantly chronic evolution with recurring episodes,
and it attains such levels of severity that seriously com-
promises one’s quality of life. Furthermore, depression’s
comorbidity with other mental health problems [5] and
with other chronic diseases is very high, and worsens
the chance of recovery [2], which further emphasizes
the need to advance in the understanding and treatment
of depression.
It is estimated that in Spain only 35.8% of patients diag-
nosed with major depression receive the minimum ad-
equate treatment [6], but even amongst these, complete
remission of symptoms is rare. In addition to drug treat-
ments, a variety of existing psychological treatments have
proved at least as effective for unipolar depression, with-
out any single one of them standing out as more effica-
cious. However, cognitive behavioral therapy (CBT) has
acquired more prestige and is backed by more research in
efficacy [7,8], without this resulting in a fully satisfactory
solution for the treatment of depression. Another issue
raised by Haby and colleagues [9] is that the said efficacy
cannot be asserted on the basis of existing research in lan-
guages other than English. Certainly, efficacy studies in
Spanish are scarce and have very small samples.
Some of these problems in treating depression may be
due to the fact that “that which we call ‘depression’ covers
different problems and processes” [10]. Perhaps, despite the
enormous amount of research and literature on the cogni-
tive factors involved in depression [11,12], we need new
conceptual advances ready to be tested in order to enrich
cognitive models of depression. In particular, contributions
that allow a better explanation of the difficulties (resistance,
relapse, recurrence) encountered in the process of change
are needed, difficulties which are also common in othermental disorders or health problems. Thus, these contribu-
tions might also be useful for the understanding and treat-
ment of a variety of clinical conditions in which change is
difficult to achieve.
Since its inception [13], cognitive therapy for depression
was based on the identification of a systematic and persist-
ent negativity in the cognitive processes of depressed pa-
tients. Thus, the identification of the negative thoughts
which invade the patient’s consciousness in an automatic
fashion is central to this therapeutic approach. Dysfunc-
tional schemas, attribution bias, rumination and perfection-
ism are also part of the cognitive model for depression,
amongst other factors [14]; however, as Beck himself re-
cently pointed out [15,16], the formulated model is incom-
plete and needs to be supplemented.
One aspect which has not been studied, and which
could contribute to explaining the difficulties of these pa-
tients achieving change, concerns the cognitive processes
related to identity conflicts. Our research group has been
working for years with a methodology capable of assessing
these conflicts and performing empirical studies to evalu-
ate its clinical importance.
The notion of cognitive conflict
Starting with psychoanalysis, a variety of theories have
suggested the existence of internal conflicts which drive
people to grueling internal struggles blocking their devel-
opment, and creating suffering and symptoms. Heider and
Festinger’s now classic formulations stand out, which pos-
tulated a motivational tendency to resolve these conflicts,
and how, when this is not attained, internal conflicts gen-
erate a state of psychological tension. Piaget himself [17]
proposed the term “cognitive conflict”, which in a devel-
opmental context serves the function of reorganizing
the intellectual processes of children. Unfortunately, and
despite the enormous relevance of this notion, it has re-
ceived little attention in recent decades, largely due to the
lack of methods providing operational and measurable
definitions.
Personal construct theory (PCT) provides an ideal con-
ceptual and methodological framework for the study of
cognitive conflicts. Far from being anchored in the rich
initial formulations of its creator [18], PCT has undergone
considerable development (see, for example, Fransella’s
Figure 1 Implicative dilemma found in a grid of a patient with
depressive symptoms. From [36]. Reproduced with permission.
Feixas et al. Trials 2013, 14:144 Page 3 of 11
http://www.trialsjournal.com/content/14/1/144extensive compilation [19] or Walker and Winter’s review
[20]). PCT emerges from a proactive view of human beings
as active agents (as later did Bandura [21]) who regulate
their motivational and emotional processes as well as their
actions, based on the congruence or discrepancy between
their construction of “self” and “ideal self” (as suggested
also by other authors [22-25]. Thus, it is understandable
for the person to encounter dilemmas or conflicts when
having to reconcile themselves with their personal values
in a decision-making process (although the person might
not be consciously aware of those conflicts).
Rowe [26] describes the case of a chronically depressed
patient who faced the choice between staying depressed
(linked in her system to being “humane”), or improving
her mood but becoming a “destructive” or “unpleasant”
person (according to her own view). In PCT, the notion of
implicative dilemma emerged to designate those conflicts
in which the desired change (for example, stop being de-
pressed) implies, in the context of the network of con-
structs forming a personal meaning system, undesired
changes in one’s vision of oneself (for example, becoming
“unpleasant”). When these conflicts occur in the construct
system of an individual, his or her capacity for change be-
comes blocked, which would be relevant to explain both
the onset of clinical symptoms as well as the resistance to
treatment. Although these cognitive conflicts can coexist
with interpersonal conflicts and with secondary gains as
postulated by other theoretical approaches, they are inde-
pendent from these and represent an innovative contribu-
tion of PCT.
The repertory grid technique (RGT) [27,28] stems from
PCT as an instrument that allows the self-concept and its
cognitive structure to be assessed. The main advantage of
this technique is that it is based on the evaluation made by
the person themselves and others through their own con-
structs or mental contents, including what they consider
their “ideal self” (see Method section for more details). It is
therefore a subjective assessment technique [29], with high
levels of utilization (see [30]), which is ideal to capture con-
flicts in personal meaning systems. The RGT has already
been applied in the study of unipolar depression (for ex-
ample, [31-33]; see Winter [34] for a review).
One of our group’s contributions is the development of a
means to evaluate conflicts in relationships between con-
structs, operationalizing the notion of implicative dilemma
(ID) through the RGT [35,36]. In the first step of our pro-
cedure, discrepant constructs are identified when scores
between the “self” and “ideal self” differ. In the second,
congruent constructs (in which there is similarity between
“self” and “ideal self”) are also identified. Next, correlations
between both groups of constructs are analyzed in pairs,
and implicative dilemmas are detected in those cases
where the desirable pole of the discrepant construct (for
example, “does not get depressed easily”) correlates withthe undesired pole of the congruent construct (for ex-
ample, “selfish”). Figure 1 offers an example of this ID. In
the construct system of the person depicted in the ex-
ample, overcoming depression in a consistent way would
also imply becoming selfish. Also, to make sure they are
really “concerned about others”, they must remain de-
pressed. So the person is immersed in a dilemma because
of the implication that the discrepant construct has for the
congruent construct (and vice versa).
Cognitive conflicts might be reflected in the RGT also
by the use of dilemmatic constructs, those in which the
“ideal self” is rated at midpoint. This might indicate that
both poles of the construct designate undesirable char-
acteristics for the self, the person thus trying to regulate
their position in the construct by avoiding the extremes.Cognitive conflicts, depression and psychotherapy
Preliminary studies with this definition of cognitive con-
flicts understood as dilemmas have shown their clinical
interest. Feixas and collagues [37] found that just over half
of a group of patients who consulted for psychotherapy
(n = 284) presented with IDs, while only a third of the
control group did (n = 322). This statistically significant
difference was not found with two other procedures used
to identify conflicts in the RGT. In addition, participants
with IDs had a higher level of symptom severity. Feixas
and colleagues [38], in a pilot study, found a higher pro-
portion (59.60%) of depressed patients with at least one ID
(versus 40.40% of the control group). Also in this study,
symptom levels were associated with the number of these
dilemmas. In a presentation of preliminary results of an
ongoing project with 81 depressive patients and improved
reliability of the RGT application, Feixas and colleagues
[39] found that although cognitive conflicts (including both
IDs and dilemmatic constructs) were not specific to de-
pression, they occurred in about 9 out of every 10 patients.
Regarding the effects of psychotherapy on IDs, Feixas
and colleagues [40] followed a group of 87 patients and
found that those who presented these conflicts to begin
with tended to resolve them by the end of psychotherapy
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and did not focus on dilemma resolution). Moreover, in
cases where this did not happen, there was less symptom-
atic improvement. This leads us to formulate the desirabil-
ity of addressing these conflicts directly in psychotherapy as
a way of enhancing its efficacy. To this end, our group has
developed a manual of dilemma-focused therapy (DFT)
published in English [41], Spanish [42] and Portuguese [43].
However, experience and data accumulated so far do not
lead us to conceive DFT as enough for a comprehensive
treatment for depression. The presence of dilemmas is not
postulated as a causative agent or as the only maintenance
factor of depression (or of any other disorder), but rather as
a cognitive structure that may hinder the process of change.
For this reason, we do not conceive treatment of depression
as using exclusively DFT, but rather propose DFT as an
additional component to a broader treatment as a way to
enhance efficacy.Justification and main hypothesis
The notion of mental or intrapsychic conflict has been
discussed for over a century by multiple theoretical ap-
proaches, but it has not been defined in measurable oper-
ational terms. The importance of said conflicts with
regard to depression has not been described either. Based
on PCT, we have developed a procedure to identify IDs, a
type of cognitive conflict, using RECORD 5.0 ([44]; the
English version GRIDCOR 4.0 is also available [27]), an
application software for the analysis of RGT data. Prelim-
inary results [39] indicate that about 90% of these patients
have at least one of the cognitive conflicts (dilemmas) as
formulated by our team based on their repertory grids.
These results justify the development of a manualized
intervention, DFT, to resolve these conflicts [41-43].
The present study aims to adapt DFT to a specific in-
dividual intervention for unipolar depression combined
with CBT in a group format, the effectiveness of the lat-
ter having been already demonstrated [45]. In order to
assess the efficacy of this combined package, it will be
compared to patients receiving CBT both in group and
individual format. If this new form of combined therapy
(group CBT plus individual DFT) exceeds the efficacy of
the condition using only CBT (group plus individual),
the project will have provided a potential improvement
which, if applied, would produce significant benefits to
depressive patients and, consequently, for society in gen-
eral. The reason for selecting CBT as the comparison
group is the well-established level of efficacy of this ther-
apy for depression, both in individual and group formats
[46]. Thus, this trial intends to test the hypothesis that
the design of an intervention module focused on the di-
lemmas identified in each patient can contribute to im-
proving the efficacy of cognitive therapy for depression.Specific objectives
 To study whether or not a combined therapy (group
CBT plus individual DFT) is more efficacious than
CBT applied in both group and individual formats.
 To check whether the degree of resolution of
cognitive conflicts (dilemmas) is greater in the
treatment condition specifically centered on
dilemmas in comparison to the well-established
CBT control treatment.
 To identify the pretreatment variables that predict
the outcome of the two treatment conditions
studied, in particular diagnosis (major depressive
disorder (MDD), dysthymic disorder (DD)),
chronicity, severity and cognitive indicators derived
from the RGT.
Pilot studies
Prior to the final version of this research protocol, two
brief non-randomized studies were conducted consecu-
tively to explore the best combination of group CBT and
individual therapies (CBT and DFT) in terms of clinical
applicability. Each study consisted of a small cohort of pa-
tients receiving a particular combination of these therapy
formats. In the first study, after initial assessment (T1) two
therapists conducted 10 group CBT sessions. Then, a new
assessment (T2) took place before the next phase of indi-
vidual therapy (10 sessions of CBT, or DFT for those pa-
tients with cognitive conflicts) carried out by different
therapists. In the post-therapy assessment (T3) clients
were interviewed in depth about the usefulness and con-
venience of the format of therapy received. They consid-
ered it helpful but mostly found the intermediate
assessment in between group and individual phases to be
an interruption of the rhythm of treatment. In discussing
the experience with therapists and supervisors it was also
estimated that both phases could be shortened to eight
sessions without major loss. A second study was then
conducted with another small cohort receiving a format of
eight group CBT sessions plus eight individual (CBT or
DFT) sessions without the intermediate assessment. In
this case, patients suggested that the continuity with the
therapist from group to individual sessions would be more
convenient. These pilot studies were useful not only for
the better adjustment of the design with respect to the
combination of the group and individual therapy formats,
but also for the adaptation of the therapy manuals to be
used in the main study.Method
Design
This study follows a controlled trial methodology to evalu-
ate the efficacy of treatments. Because DFT is not
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as an ingredient which can be added to other therapies,
the study is designed to test the efficacy of a combined
package which includes DFT as a substantial component.
As a comparison group we use CBT for depression, a
treatment package with a well-established effectiveness
both in individual and in group formats. Since DFT so far
can only be applied in the individual format (because it fo-
cuses on the dilemmas identified specifically for each pa-
tient), group CBT is included as a shared part of both
treatment conditions. This treatment modality has already
been proven effective (to levels comparable to individual
CBT format) and also more efficient in terms of treatment
costs. In summary, all patients receive group CBT, and
added to this condition is a component of individual ther-
apy which, depending on randomization, can be CBT or
DFT. For each treatment condition a therapy manual has
been adapted for the specific format of the study. The de-
sign of the clinical trial is depicted in Figure 2.Setting
The study will be conducted at various mental health cen-
ters in the Barcelona area: CSM Nou Barris, Associació
Catalana de Teràpies Cognitives (ACTC) and others be-
longing to Hospital de Mataró, Parc de Salut Mar (Santa
Coloma), and to Fundació Sant Pere Claver. Furthermore,
patients will be recruited from primary care centers and
treated either in those centers or at ACTC.Participants
Since this is the first controlled study of DFT, no previous
data are available on which to base our estimations. How-
ever, according to other studies comparing CBT with
a variety of other therapies (see the meta-analysis by
Gloaguen and colleagues [47]), we estimated medium
between-group effects. Thus, to determine the sample size
we calculated that, with a statistical power of 0.80, consid-
ering a dropout rate of 20%, an α significance level of 0.05
(two-sided) and an effect size of 0.30, we require a total of
112 patients. In terms of our primary outcome measure
(Beck depression inventory, second edition (BDI-II), see
below) and based on Spanish normative data, calculation
yielded a 3.3-point difference between groups.Inclusion criteria
All participants will meet diagnostic criteria for MDD or
DD according to the Diagnostic and Statistical Manual of
Mental Disorders (4th edition, text revision) (DSM-IV-TR)
[48] and a score above 19 on the BDI-II questionnaire.
Once the RGT is administered only those patients who
have at least one cognitive conflict are included in the
treatment phase of the study, which based on previousdata [39] should be 90% of the cases. The age range is be-
tween 18 and 70 years.Exclusion criteria
Patients presenting bipolar disorders, psychotic symptoms,
substance abuse, organic brain dysfunction, acute suicidal
ideation or mental retardation will be excluded from the
study. Those who are receiving psychological treatment
will not be accepted either, unless it is suspended at the
time of inclusion in the study itself, in agreement with the
patient and the therapist who is applying it. The presence
of other comorbid conditions (anxiety, eating or personal-
ity disorders, etc.) and consumption of psychotropic drugs
will not be cause for exclusion but they will be assessed
and recorded for statistical control. Finally, those who do
not have enough level of competence to communicate in
Spanish or Catalan, or patients with substantial visual,
hearing and cognitive deficits cannot be included.
Instruments
– Structured clinical interview for DSM-IV axis I
disorders (SCID-I) [49] for the diagnosis of mental
disorders and collection of socio-demographic data,
psychotropic drug consumption, and treatments
received.
– BDI-II [50,51], a 21-item self-report instrument to
assess the existence and severity of symptoms of
depression. It has good psychometric properties and
acceptability. This is the main outcome measure.
– Clinical outcomes in routine evaluation-outcome
measure (CORE-OM) [52], a 34-item self-report
questionnaire for the assessment of subjective well-
being, symptoms or problems, life functioning and
risk. It has good psychometric properties and it has
been adapted into Spanish for free distribution
recently [53]. The short form B of the clinical
outcomes in routine evaluation-outcome measure
(SFB) of 18 items will be used for session-to-session
monitoring of the therapy process.
– Hamilton rating scale for depression (HAMD) [54]
is the most widely used outcome measure in clinical
trials for depression. It is a clinician-rated 17-items
instrument with good psychometric properties.
– RGT [27] for assessing the presence, number and
severity of cognitive conflicts. It is a semi-structured
interview oriented at the elicitation of personal
constructs and their assessment as they are applied
to a set of significant others (for a more detailed
description of the format used in this study see
[36]). Other repertory grid measures assessing the
construction of self and cognitive structure will be
examined in another study.
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Group cognitive behavioral therapy
A comprehensive therapy manual [Bados and García-
Grau, Terapia cognitivo-conductual de la depresión: Man-
ual de tratamiento en grupo. Universitat de Barcelona.
Unpublished manuscript] has been created for this study
based in Beck’s cognitive therapy manual [13] and two
more recent publications [55,56]. The manual has beenFigure 2 Clinical Study Design. BDI-II, Beck depression inventory, second
outcomes in routine evaluation-outcome measure; HAMD, Hamilton rating
clinical interview for DSM-IV axis I disorders; CORE-SFB, short form B of theadapted to eight group sessions of approximately 120 mi-
nutes in length. This treatment will be applied to all pa-
tients in the study, led by two therapists, both licensed
psychologists with sufficient experience and training to
carry it out. The groups will be formed with 6 to 8 pa-
tients, and thus it is estimated that between 14 and 18
therapy groups will be conducted. Furthermore, once the
seventh session is finished, patients will receive (followingedition; CBT, cognitive-behavioral therapy; CORE-OM, clinical
scale for depression; RGT, repertory grid technique; SCID-I, structured
clinical outcomes in routine evaluation-outcome measure.
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psychotherapy compared in this study (CBT or DFT) by
the same group therapists (one in each condition). Once
this phase of individual sessions is done, another group
CBT session lasting 180 minutes (with a break) will be
scheduled. This final session, focused on relapse preven-
tion, is thought to also provide a sense of continuity for all
the therapy process and reunion of all patients and thera-
pists involved.
Individual cognitive behavioral therapy
Patients assigned to this condition will receive CBT fol-
lowing a complementary manual [Bados and García-Grau,
Terapia cognitivo-conductual de la depresión: manual de
tratamiento individual. Universitat de Barcelona. Unpub-
lished manuscript] based on the same sources as above.
The manual has been adapted to eight sessions of approxi-
mately 60 minutes and to the fact that patients have re-
ceived group CBT previously. The therapist will also have
conducted that group.Individual dilemma focused therapy
Patients assigned to this condition will receive DFT follow-
ing the manual designed specifically for this project [Feixas
and Compañ, A dilemma-focused intervention for unipolar
depression: individual treatment manual. Universitat de
Barcelona. Unpublished manuscript], based on Feixas and
Saúl [41] and Senra and colleagues [42]. Since this type of
intervention has never been tested before, the process for
creating this manual followed the indications of Carroll
and Nuro [57] for the development of therapy manuals.
The therapy will consist of eight sessions of approximately
60 minutes.
In DFT manuals (and in very general terms), the first
session comprises welcoming and establishing rapport,
analysis of demand, therapy goals definition, and identifi-
cation of main dilemmas. Subsequently, feedback of the
results of the evaluation is provided and the presenting
problem(s) or symptom(s) is reframed in terms of the di-
lemma(s). Next, work on the dilemma(s) is conducted
over several sessions, and the therapeutic process is com-
pleted with the revision of the work done on dilemma(s)
and future prospects. During all phases, techniques origin-
ating from personal construct therapy are used (for ex-
ample, see [58]). As in the CBT condition, the therapist
will have previously conducted group therapy with these
patients.
Procedure
This study was approved by the Committee for Ethics in
Research of the University of Barcelona under the number
(IRB00003099) and also by the ethical committees of the
other centers involved in the study. It is registered atClinicalTrials.gov under number NCT01542957 and also
at Current Controlled Trials (ISRCTN92443999).
Professionals of collaborating centers will be asked to in-
form their patients with major depression or dysthymia of
the existence of this psychological treatment study and en-
able us to contact those who accept the opportunity to
participate. For each center, an information sheet for po-
tential participant patients and another for professionals
with information on how to refer patients for the study
were created. Finally, to reach a wider population range, a
web page (www.ub.edu/terdep) and a flyer have been pro-
duced for the study. After referral by telephone or email,
patients will be contacted to arrange for the selection and
assessment process.
Initial assessment
The initial assessment (T1) will be carried out in three
phases. Firstly, the nature of the study is explained and, if
the patient agrees to participate and signs the informed
consent, the BDI-II is applied to verify the clinically sig-
nificant presence of depressive symptoms (a score above
19). Secondly, patients meeting this criterion will be evalu-
ated using the SCID-I interview to confirm the diagnosis
of MDD or DD (if this is not the case, they will be ex-
cluded) and explore for other comorbid disorders. The
section “Overview” included in this interview will also be
used to collect socio-demographic data and information
relative to previous treatments, to clarify that they are not
receiving and will not receive any other concurrent psy-
chological treatment, and to record psychotropic drug
consumption. A few other instruments will also be used in
this and further assessment sessions as part of another
study. With patients selected in this phase, a second as-
sessment session will be scheduled in the following weeks.
In this third phase, the CORE-OM and the RGT will be
administered. The resulting data will be analyzed with the
RECORD 5.0 software [27,44]. On the following day, they
will be contacted to confirm their inclusion in the study
(if they have at least one cognitive conflict) or exclusion
(in which case a way of providing the appropriate assist-
ance to them will be sought together with the profes-
sionals from the center where they came from). The
evaluators will be psychology graduate students (or ad-
vanced undergraduates) who will have been specially
trained to perform the entire assessment process, as in
particular the SCID-I and the RGT interviews require spe-
cific training, and they will be, at this point, blind in regard
to the treatment modality which will be assigned to the
patients. Two evaluators will conduct the assessment
process for each potential participant.
Beginning of the treatment and randomization
Once assessed and accepted for the study, patients will be
summoned individually to a meeting with their therapists
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and individual therapy, and then convened for the first
CBT group session. In this meeting and at the beginning of
the consecutive 16 therapy sessions, the CORE-SBF will be
administered for routine evaluation of the therapy process
and to monitor suicide risk. Whenever patients rate 3 or 4
on item 5 (suicide plans) they will be given special atten-
tion after the group session for a more careful assessment
of suicide risk as specified in the therapy manual.
Once the first phase of seven group sessions is finished,
they will be randomly assigned to one of the two individual
treatment conditions (CBT or DFT) which will begin fol-
lowing the group therapy. Randomization will be done
using permuted blocks with a random assignment online
application [59] by a staff member of the Department of
Personality, Assessment and Treatment of the University
of Barcelona, completely oblivious to the study and blind
to treatment conditions. Therefore, group CBT therapists
can only know of patient allocation after the first phase of
group treatment is completed, right at the moment they
have to start individual therapy. In any case, therapists will
not have participated in the initial evaluation of those pa-
tients nor will they in any subsequent assessments.
Treatments will be carried out mostly in the health
centers corresponding to the patients according to the
Catalan Public Health System, both in the common
group format and in the two individual treatment condi-
tions. If, eventually, the treatment cannot be carried on
in these centers, patients will be invited to participate in
the groups of ACTC. Groups will be formed in the vari-
ous centers as soon as 8 patients have been admitted to
the study and agree to initiate the proposed treatment.
Therapists will be graduate students enrolled in the
master in Cognitive Social Therapy at the University of
Barcelona. This is not a research-oriented course but ra-
ther a 3-year program designed to provide therapy training.
Both group and individual sessions will be recorded on
audio (which is also reflected in the informed consent).
This will allow supervision of each session from members
of the team with more clinical experience who will evaluate
the performance of the therapists in order to maximize
their adherence to the relevant manual and ensure that
therapy is beneficial for its recipients. Before the start of
the treatment, differentiated training workshops will be de-
veloped for each type of treatment to provide therapists
with specific training in the protocols for individual and
group therapy used in the study.
Consecutive assessments, termination and follow-up
Once the individual therapy phase is terminated, a second
assessment (T2) of all initial measures will be carried out
by the same pair of evaluators who conducted the initial
assessment (whenever possible), blind to the therapeutic
condition of each patient. In the following week the finalgroup session will take place and a more qualitative assess-
ment session (as part of a complementary study) will take
place in another week. There will also be follow-up assess-
ments at 3 months (T3) and 1 year (T4) after completion
of treatment to check the degree of maintenance of the ac-
complished changes. Finally, one (or occasionally two)
booster sessions will be offered to all patients during the
fourth month after treatment termination.
Treatment integrity
For group CBT and the individual CBT arm of the study,
therapist adherence will be assessed using the revised cog-
nitive therapy scale (CTS-R) [60]. Because there are no
pre-existing adherence/fidelity measures for DFT, a scale
will be created to measure therapist adherence to this indi-
vidual therapy arm.
Two trained clinical graduate students will independently
rate a random selection of sessions using the CTS-R for
the group sessions and both scales for the individual ones.
Inter-rater reliability and success at discriminating between
the content of the CBT and DFT will be computed.
Patient’s treatment compliance will be monitored by at-
tendance and homework completion.
Statistical analyses
All data derived from the measurements and the clinical
data (including use of psychotropic drugs) and socio-
demographic information will be entered into Statistical
Package for Social Sciences version 20.0 or later (IBM Cor-
poration, Armonk, New York, USA). The main statistical
calculations will be performed on an intention-to-treat
basis (patients will be analyzed as initially randomized).
Categorical data will be summarized as frequencies and
percentages. Means and standard deviations will be used
for continuous data for which normality tests will also be
performed.
Analyses will include elementary head-to-head compari-
sons of the intervention groups as well as mixed models
of repeated measures analysis of variance in which initial
measures (baseline) of the dependent variables will be
used as covariates. Sociodemographic and clinical differ-
ences between patients in response to treatment (such as
diagnosis of MDD or DD, and chronicity) will be explored,
as well as the potential mediator or moderator role of the
cognitive measures obtained with the RGT, especially in
regard to the number and intensity of cognitive conflicts.
In fact, additional analysis will take these conflicts as a
dependent variable to observe how they have varied with
the different treatments. Also as secondary analyses, the
inclusion of the CORE-OM/SFB in the study will allow
the examination of the degree of therapeutic change in
other aspects, such as the patients’ psychosocial function-
ing and subjective well-being. Moreover, it will also allow
assessment of the change experienced in relation to the
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session. In all the analyses which permit it, and depending
on the variations found between the groups, patient
drug consumption will be statistically controlled. In all
statistical contrasts, derived confidence intervals will be
taken into account as well as their effect sizes.
Finally, we will calculate the proportion of patients with
a reliable and clinically significant improvement on the
BDI-II, HAMD-17 and CORE-OM outcome measures.
We will follow Jacobson and Truax [61] who established
that clinical improvement is based on both reliable change
(the extent to which pre-to-post-difference scores are reli-
able) and on clinical significant change (the extent to
which post-treatment scores are clinically meaningful).
Chi-square tests will be used to test the frequency differ-
ences in these categories between the two intervention
groups.
Discussion
Despite advances in its prevention and treatment, depres-
sion is nowadays one of the most serious health problems
we encounter, both for its morbidity as well as its disabling
effects. This is a problem with major implications on the
lives of those affected and their families, as well as a major
social and health burden. Most cases do not fully remit
and, for those who do, recurrence is very common. This
persistence (sometimes intermittent) of the depressive dis-
comfort is one of the most difficult issues to resolve in
the field.
Cognitive models have made a significant advance in the
understanding of depression and have come a long way
since initial formulations. Thus, therapeutic targets (for ex-
ample, activity scheduling, identifying automatic thoughts,
etc.) emerged and were identified to guide CBT. However,
only partial progress has been accomplished so far in the
treatment of depression. The existence of conflicts or di-
lemmas in the cognitive structure is more prevalent in de-
pression, and could explain the blockage and relapses that
characterize these patients, especially the more severe and/
or chronic. Our hypothesis is not that these cognitive con-
flicts are the cause or the main factor maintaining the de-
pression, but rather we believe the dilemmas commonly
found in depressive patients [38,39] might reveal that their
discomfort is congruent with a part of their cognitive sys-
tem (while for another part the change is desirable). If
these dilemmas are identified they should become a focus
of the psychological intervention so as to not hinder the
process of change. In cognitive-behavioral treatment of de-
pression, cognitive conflicts may go unnoticed in many
cases, or may not receive sufficient attention. Therefore,
this study aims to test whether the addition of a specific
module focused on working with dilemmas can result in a
significant increase of the efficacy of cognitive therapy for
depression. Presumably this combined intervention willbenefit to a greater extent those patients who are more se-
vere or with a higher chronicity, with the personal, social
and economic consequences that this condition entails.
This particular design, however, does have some limi-
tations. Even if results show the superiority of the DFT
arm, their success cannot be attributed only to DFT but
to its combination with group CBT. Conversely, if the
arm including DFT does not show better outcome re-
sults than the comparison CBT package, this would not
rule out the possibility that individual DFT could be ef-
fective. In fact, it could be effective in combination with
other treatments. Still the design of the study can be in-
formative as a first step in testing the relative efficacy of
DFT in terms of pursuing further investigation with this
treatment modality. Also, the fact that treatments are
applied by novice therapists might lessen the potential
effects of the treatments being tested. For that purpose,
as said, clinical supervision is carefully provided in the
study but that might not be enough for the treatments
to be applied with a high level of competence. An add-
itional limitation of the study is that, although we plan
to collect up to 1-year follow-up data, a longer period
might be more convenient for properly considering re-
lapse and recurrence as outcome variables.
In addition to the main goal of this study, other add-
itional benefits might also be attained with the imple-
mentation of this study. First, the development and
adaptation of therapy manuals eases the dissemination
of these psychological treatments amongst professionals
working in Spanish and their further application in clin-
ical practice. Moreover, they provide a useful tool for
training novice therapists, improving the competence of
more experienced therapists and facilitating the develop-
ment of new empirical studies. Since DFT will have been
applied by relatively novice therapists (graduate students
in training), it is expected that the adoption of this treat-
ment by more experienced professionals will not be diffi-
cult. However, further investigation should be made to
study whether more seasoned therapists who had been
working in clinical practice for years find the DFT man-
ual feasible to learn and to apply it with their patients.
Second, it will contribute to provide further evidence in
Spain of CBT for depression in general, regardless of
whether intervention with dilemmas adds value to them
or not. Indeed, there are few controlled studies with suf-
ficiently large sample sizes in our country or in lan-
guages other than English [9], and thus the effectiveness
of these therapies needs to be confirmed. Finally,
this will be the first randomized clinical trial using
CORE-OM in Spanish, which also contributes in this re-
gard. As an instrument specializing in measuring thera-
peutic change used in many public and private health
centers in the UK, its use in this study will confirm its
usefulness also in Spanish.
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experts and trainers while a few others are well known
in the constructivist therapies. The inclusion in the team
of researchers with different theoretical orientations and
closely linked to the two types of intervention modalities
that are subjected to empirical testing aims to control for
an allegiance effect of the researcher on the study results
[62]. Another advantage of the present team composition
is the inclusion of international experts on psychotherapy
research and on DFT/constructivist therapy who act as
consultants for the entire research process.
In case of favorable outcome it would be convenient for
other independent research groups to replicate this study
so that the combination of group CBT and individual DFT
may be considered an efficacious and specific treatment.
Moreover, further studies should address the limitations of
controlled studies, especially in regard to its generalization
and dissemination among clinicians. However, this study
will be implemented in a way that will secure high levels
of generalizability. On the one side, most patients will be
recruited and treated in their primary care or mental
health centers. On the other, therapists’ level of experience
will be relatively low so the impact of the therapy manuals
might be more substantial. To potentiate this factor,
supervision and careful analysis of therapists’ adherence to
the manual will be performed by experienced therapists.
Therefore, results of the study should be generalizable to
novice therapists working in naturalistic settings.
Future studies might also explore whether this DFT
module increases the efficacy of not only CBT but also of
other treatments for depression such as interpersonal
therapy or emotion-focused therapy. In all these possible
studies, cost-benefit analysis would be informative as well.
Trial status
Recruitment of participants is ongoing; it began in
November 2011 and is expected to end in June 2014.
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